Filipa Siopa

Dr. Filipa Siopa

Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2014 in Ecotoxicology and Environmental Safety
Verified
Journal Article
Closed access
FSFrancisca A. e Silva
Francisca A. e Silva
FSFilipa Siopa
Filipa Siopa
BFBruna F.H.T. Figueiredo
Bruna F.H.T. Figueiredo
Ana Marta GonçalvesAna Marta Gonçalves
Ana Marta Gonçalves
Joana Luisa PereiraJoana Luisa Pereira
Joana Luisa Pereira
SVSonia P. M. Ventura
Sonia P. M. Ventura

1 June 2013 in Chemosphere
Verified
Journal Article
Closed access
RFRaquel F.M. Frade
Raquel F.M. Frade
SSSvilen P. Simeonov
Svilen P. Simeonov
ARAndreia Almeida Rosatella
Andreia Almeida Rosatella
FSFilipa Siopa
Filipa Siopa
CACarlos Afonso
Carlos Afonso

21 April 2011 in British Journal of Pharmacology
Verified
Journal Article
Open access
PDF file
Daniel José BarbosaDaniel José Barbosa
Daniel José Barbosa
João Paulo CapelaJoão Paulo Capela
João Paulo Capela
Jorge M. A. OliveiraJorge M. A. Oliveira
Jorge M. A. Oliveira
RSRenata Silva
Renata Silva
Luisa FerreiraLuisa Ferreira
Luisa Ferreira
Félix CarvalhoFélix Carvalho
Félix Carvalho
BACKGROUND AND PURPOSE: 3,4‐Methylenedioxymethamphetamine (MDMA or ‘Ecstasy’) is a worldwide major drug of abuse known to elicit neurotoxic effects. The mechanisms underlying the neurotoxic effects of MDMA are not clear at present, but the metabolism of dopamine and 5‐HT by monoamine oxidase (MAO), as well as the hepatic biotransformation of MDMA into pro‐oxidant reactive metabolites is thought to contribute to its adverse effects.EXPERIMENTAL APPROACH: Using mouse brain synaptosomes, we evaluated the pro‐oxidant effects of MDMA and its metabolites, α‐methyldopamine (α‐MeDA), N‐methyl‐α‐methyldopamine (N‐Me‐α‐MeDA) and 5‐(glutathion‐S‐yl)‐α‐methyldopamine [5‐(GSH)‐α‐MeDA], as well as those of 5‐HT, dopamine,l‐DOPA and 3,4‐dihydroxyphenylacetic acid (DOPAC).KEY RESULTS: 5‐HT, dopamine,l‐DOPA, DOPAC and MDMA metabolites α‐MeDA, N‐Me‐α‐MeDA and 5‐(GSH)‐α‐MeDA, concentration‐ and time‐dependently increased H2O2production, which was significantly reduced by the antioxidants N‐acetyl‐l‐cysteine (NAC), ascorbic acid and melatonin. From experiments with MAO inhibitors, it was observed that H2O2generation induced by 5‐HT was totally dependent on MAO‐related metabolism, while for dopamine, it was a minor pathway. The MDMA metabolites, dopamine,l‐DOPA and DOPAC concentration‐dependently increased quinoproteins formation and, like 5‐HT, altered the synaptosomal glutathione status. Finally, none of the compounds modified the number of polarized mitochondria in the synaptosomal preparations, and the compounds’ pro‐oxidant effects were unaffected by prior mitochondrial depolarization, excluding a significant role for mitochondrial‐dependent mechanisms of toxicity in this experimental model.CONCLUSIONS AND IMPLICATIONS: MDMA metabolites along with high levels of monoamine neurotransmitters can be major effectors of neurotoxicity induced by Ecstasy.

11 November 2016 in ChemistrySelect
Verified
Journal Article
Closed access
PDF file
FSFilipa Siopa
Filipa Siopa
TFTeresa Figueiredo
Teresa Figueiredo
RFRaquel F. M. Frade
Raquel F. M. Frade
INIris Neto
Iris Neto
AMAna Meirinhos
Ana Meirinhos
Patrícia RijoPatrícia Rijo
Patrícia Rijo

1 December 2008 in Carbohydrate Research
Verified
Journal Article
Closed access
TFTiago Q. Faria
Tiago Q. Faria
AMAna Mingote
Ana Mingote
FSFilipa Siopa
Filipa Siopa
MVM. Rita Ventura
M. Rita Ventura
CMChristopher D. Maycock
Christopher D. Maycock
HSHelena Santos
Helena Santos

16 July 2015 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
DHDiego O. Hartmann
Diego O. Hartmann
Karina ShimizuKarina Shimizu
Karina Shimizu
FSFilipa Siopa
Filipa Siopa
MLM. Cristina Leitão
M. Cristina Leitão
CACarlos Afonso
Carlos Afonso
CPCristina Silva Pereira
Cristina Silva Pereira
Understanding the mechanisms of toxicity of ionic liquids at the molecular level is crucial for their conscious design as to promote higher acceptability as green solvents in a wide range of applications. In this systematic study, we investigated the effects of three families of ionic liquids on the plasma membrane of the filamentous fungus Aspergillus nidulans. Using fluorescence microscopy and gene expression analysis, we were able to demonstrate that the widely studied 1-alkyl-3-methylimidazolium chlorides with long alkyl substituents cause membrane permeabilisation. In opposition, the biocompatibility of cholinium alkanoates was reinforced here, even though their toxicity also increases with the elongation of the anion. Further investigating the effects of charge on membrane permeabilisation, we observed that a series of alkyl-(2-hydroxyethyl)-dimethylammonium bromides led to permeabilisation of the fungal plasma membrane by increasing the length of one alkyl substituent in the cholinium cation. We hypothesise that the chemical nature of the plasma membrane, which presents a heterogeneous charge distribution along its surface, is pivotal for the membrane permeabilising effects of ionic liquids. This study may inspire a new trend in the ionic liquid field: to give preference for the development of compounds carrying functionalised anions as greener alternatives to those carrying functionalized cations.